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Abstract
Background: Pain is still one of the most frequently occurring symptoms at the end of life, although it can be
treated satisfactorily in most cases if the physician has adequate knowledge. In the Netherlands, almost 60% of the
patients with non-acute illnesses die at home where end of life care is coordinated by the general practitioner
(GP); about 30% die in hospitals (cared for by clinical specialists), and about 10% in nursing homes (cared for by
elderly care physicians).
The research question of this study is: what is the level of knowledge of Dutch physicians concerning pain
management and the use of opioids at the end of life?
Methods: A written questionnaire was sent to a random sample of physicians of specialties most often involved in
end of life care in the Netherlands. The questionnaire was completed by 406 physicians, response rate 41%.
Results: Almost all physicians were aware of the most basal knowledge about opioids, e.g. that it is important for
treatment purposes to distinguish nociceptive from neuropathic pain (97%). Approximately half of the physicians
(46%) did not know that decreased renal function raises plasma concentration of morphine(-metabolites) and 34%
of the clinical specialists erroneously thought opioids are the favoured drug for palliative sedation.
Although 91% knew that opioids titrated against pain do not shorten life, 10% sometimes or often gave higher
dosages than needed with the explicit aim to hasten death. About half felt sometimes or often pressured by
relatives to hasten death by increasing opioiddosage.
The large majority (83%) of physicians was interested in additional education about subjects related to the end of
life, the most popular subject was opioid rotation (46%).
Conclusions: Although the basic knowledge of physicians was adequate, there seemed to be a lack of knowledge
in several areas, which can be a barrier for good pain management at the end of life. From this study four areas
emerge, in which it seems likely that an improvement can improve the quality of pain management at the end of
life for many patients in the Netherlands: 1)palliative sedation; 2)expected effect of opioids on survival; and
3) opioid rotation.
Background
Many factors may hamper optimal pain management
such as patient nonadherence to drug therapy, underre-
porting of pain or miscommunication between patient
and caregivers; from a healthcare provider perspective,
inadequate assessment of pain, poor documentation and
miscommunication may limit optimal pain management
[1]. To achieve good patient care at the end of life, also
adequate knowledge of pain management and opioids
among physicians is essential. Pain is still one of the
most frequently occurring symptoms at the end of life,
although it can be treated satisfactorily in most cases if
the physician has adequate knowledge [2-7].
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Among countries, different physicians are involved in
pain treatment at the end of life. In the Netherlands,
health care is characterised by its strong emphasis on
primary care, where the family physician is the central
professional in the management and coordination of the
patient’s care [8]. Almost 60% of the patients with non-
acute illnesses die at home where palliative care is coor-
dinated by the general practitioner (GP) [9]. About 30%
of the patients with non-acute illnesses die in hospitals
(cared for by clinical specialists), and about 10% in nur-
sing homes (where the elderly care physician - formerly
known as nursing home physician - is responsible) [9].
It is estimated that 5% of all people die in a specialised
palliative care unit. These units are part of nursing
homes or homes for the elderly (50%), or hospices (50%)
[10]. Characteristic for the Netherlands is that euthana-
sia is a legal option when suffering is unbearable and
hopeless; in 2005, 1.7% of all deaths was the result of
euthanasia [11].
Elderly care physicians usually work in a single organi-
sation, and are trained to care for elderly patients,
including end of life care [12,13]. A wide range of clini-
cal specialists provide end of life care in hospitals, and
they also consult their colleagues in general practice and
nursing homes to discuss complex symptoms in end of
life care: for example 55% of the GPs cooperate with a
clinical specialist [14]. In palliative home care, GPs fre-
quently cooperate with district nurses [14] and can con-
sult a regionally working palliative care consultation
team [15].
In all these settings, possibilities to treat patients at
the end of life with medication have increased in the
past decade. Being able to take advantage of these possi-
bilities does require physicians to maintain their knowl-
edge. Guidelines that are developed by medical
professional organizations can be a useful tool for this
purpose.
Initially, there was optimism that the availability of
evidence-based guidelines about pain management at
the end of life would lead to great improvements in
care. Research in the US showed that the problem of
suboptimal pain management was far more complex
than previously suspected: certain myths about the ben-
efit of pain and the disadvantages and limitations of
treatment of pain are to such an extent assimilated in
the collective knowledge, that they are not banished by
simply stating in a guideline that they are false [16].
Examples of such widespread myths are that pain often
is inevitable, that administering increasing dosages of
opioids hastens the end of life, and that adverse effects
of opioids, such as drowsiness and confusion are inevita-
ble [16-24].
In the international literature, the main focus of the
effect of such myths is that opioids are underdosed, as a
consequence of which patients may suffer needlessly
[16,20,21]. Studies in the Netherlands have also shown
that physicians treating cancer pain do not always follow
evidence-based guidelines [25-27]. Another risk of
myths can be that physicians overdose opioids, e.g. if
they intend to hasten the end of life, and think they can
attain this goal by increasing the dosage further than is
required for pain management.
Developing and dispersing evidence-based guidelines
is an important step towards an evidence-based practice,
but further steps are required. To improve the quality of
care at the end of life, it is subsequently necessary to
study which knowledge has and which has not perme-
ated to physicians, and which myths may hinder further
permeation.
We aimed to study the level of knowledge of physi-
cians, including both knowledge that should be familiar
ground to all physicians, and facts that have more
recently been added to the body of evidence, but should
also be known to physicians involved in end of life care.
Furthermore, we aimed to study experiences of physi-
cians with pain management and opioids at the end of
life, and possible barriers to good pain management at
the end of life according to physicians.
Methods
Medical ethical approval was not necessary for this
study in the Netherlands because it was a cross-sectional
questionnaire study among physicians, patients were not
involved and no interventions were done.
Developing the questionnaire and the pilot study
For this study, we developed a questionnaire to investi-
gate knowledge and attitude concerning opioids and
pain management at the end of life, based upon pre-
vious studies [19,20,28-34]. Questions were adapted and
added to be able to answer the research questions, and
to fit the specific situation in the Netherlands. For this
purpose we used Dutch guidelines, original articles and
review articles [17,22,23,35-53].
The questionnaire consisted of three types of ques-
tions: 1) knowledge statements with three answering
options: “true”, “false” and “don’t know” 2) experience
and attitude questions with five answering options:
“completely agree”, “agree more than disagree”,
“neutral”, “disagree more than agree” and “completely
disagree” and 3) other experience and attitude questions,
partly structured with four answering options: “often”,
“sometimes”, “seldom” and “never” and partly semi-
structured. Furthermore several background characteris-
tics were asked, including to grade their own knowledge
about opioids and pain management by scoring 1-10.
After completing the knowledge statements, respondents
were asked to again grade their own knowledge.
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The questionnaire was piloted among general practi-
tioners in training (n = 54) and elderly care physicians in
training (n = 24). Most physicians in the pilot indicated
they used 15 minutes to complete the questionnaire. Opi-
nions differed on the difficulty level of the knowledge
statements in the questionnaire, but most physicians (79%)
did not think the statements were too difficult or they
even thought they were (too) easy. The translated ques-
tionnaire is presented as an appendix in additional file 1.
Sampling frame
Physicians from the specialties which are most involved
in pain management at the end of life were included in
the random samples, namely: general practitioners,
elderly care physicians, and clinical specialists specialized
in internal medicine (incl oncologists, excl gastrointest-
inal and hepatic physicians), pulmonology, surgery (excl
orthopaedics and plastic surgeons), cardiology, neurol-
ogy, and anaesthesia. Geriatricians were not included in
the sample as this is a small specialism in the Nether-
lands. The samples were randomly taken from different
sources: general practitioners from the Netherlands Insti-
tute of Health Services Research (NIVEL), elderly care
physicians from the Association of Physicians specialized
in care for older people (Verenso) and clinical specialists
from the medical address guide (BSL). These registra-
tions consist of virtually all general practitioners, elderly
care physicians and clinical specialists in the Netherlands.
Including criteria were: currently working in the Nether-
lands as a physician, not in training.
Data collection and anonymity
The questionnaire was sent in January 2009. Two remin-
ders were sent. The first reminder was a letter or an
e-mail to remind them of the study, the second reminder
included the questionnaire again and a short non-
response questionnaire. Respondents could complete the
questionnaire on paper or online. The written question-
naire was anonymous. A separate answer card with the
personal data of the respondent could be mailed sepa-
rately by the respondent to prevent further reminders.
The online questionnaire was not anonymous, because it
would otherwise not be possible to exclude the possibility
that people who were not in the sample would complete
the questionnaire. When the database was closed the
questionnaires were made anonymous.
After the closing of the data collection, a document
with the correct answers to the statements to test
knowledge was sent by e-mail to the respondents who
had indicated they were interested to receive this.
Analysis
All returned questionnaires were included in our analy-
sis. Differences between non-responders and responders,
and between general practitioners, elderly care physi-
cians and clinical specialists were calculated using chi
square tests. A significance level of p < 0.05 was used.
Answers “completely agree” and “agree more than dis-
agree” were merged to the category “agree” when
describing attitudes and experiences concerning pain,
the prescription of opioids and consultation. A linear
regression analysis was done with as a dependent vari-
able the number of correct answers to the knowledge
statements. The analysis was done backward stepwise
until all independent variables had a p < 0.05 to con-
struct a predictive model.
Results
Background characteristics
In Table 1 the background characteristics of the respon-
dents are shown per specialty. Clinical specialists are
employed full-time more often than general practi-
tioners and elderly care physicians, and clinical specia-
lists had most experience with prescribing opioids.
Elderly care physicians had more experience with non-
sudden deaths than clinical specialists and general prac-
titioners and elderly care physicians had most often
received a specific education in palliative care, apart
from the regular medical education. Patients who were
treated by the general practitioner at the moment of
death were prescribed opioids more often than patients
treated by clinical specialists or elderly care physicians
at the moment of death.
Response rate and non-response analysis
In total 1044 physicians were sent a questionnaire, 55
envelopes were returned to sender, leaving 989 possible
respondents. Of the 400 general practitioners, 182 com-
pleted the questionnaire (response rate 46%), of the 175
elderly care physicians, 110 completed the questionnaire
(response rate 63%), and of the 414 clinical specialists,
112 completed the questionnaire (response rate 27%), 2
physicians completed the questionnaire, without specify-
ing their specialty. The total response rate was 406/989
= 41%. Of the completed questionnaires, 80% was com-
pleted in writing and 20% was completed online. The
non-response questionnaire was completed by 29 gen-
eral practitioners, 6 elderly care physicians, and 43 clini-
cal specialists.
There were several significant differences between
physicians who completed the non-response question-
naire (n = 78) and physicians who completed the full
questionnaire (n = 406) (not in Table). The non-
response questionnaire was completed significantly
more often by clinical specialists (55% of the non-
response questionnaires were completed by clinical spe-
cialists vs. 28% of the full questionnaires). Physicians
who completed the non-response questionnaire were
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Table 1 Background characteristics of respondents
General
practitioners
Elderly care
physicians
Clinical
specialists
p-value* Total
n = 182 n = 110 n = 112 n = 406†
% % % %
Gender <0.05
• Men 63 36 70 58
• Women 36 65 30 42
Age (years) ≥0.05
• <40 20 31 13 21
• 41-50 32 33 40 35
• 51-60 41 35 41 39
• >60 7 1 6 5
Employment <0.05
• full-time 54 27 80 55
• part-time 43 71 20 45
Grade given for own knowledge before completing the
questionnaire (1-10)
<0.05
• <5.5 3 2 9 4
• 5.5-6.5 13 6 15 11
• 6.6-7.5 56 52 39 50
• 7.6-8.5 27 38 29 30
• 8.6-10 2 3 8 4
Grade given for own knowledge after completing the
questionnaire (1-10)
<0.05
• <5.5 2 1 13 5
• 5.5-6.5 10 9 17 12
• 6.6-7.5 53 53 39 49
• 7.6-8.5 33 34 28 32
• 8.6-10 2 3 5 3
Received specific education in palliative care apart from regular
medical education
77 90 43 <0.05 71
Number of patients to whom the respondent had prescribed
opioids in 2008
≥0.05
• None 0 2 3 1
• 1-5 5 2 13 6
• 6-20 43 28 24 33
• 21-50 35 46 20 34
• >50 16 21 42 25
Number of deaths after a sickbed (non-sudden) in 2008 while
being treating physician
<0.05
• None 0 0 11 3
• 1-5 35 5 15 21
• 6-20 59 39 49 50
• 21-50 6 47 17 21
• >50 1 9 9 5
Percentage of these patients that were using opioids at the
moment of death‡
<0.05
• None 1 1 8 2
• 1-40% 17 16 36 22
• 41-80% 46 66 42 51
• 81-100% 37 17 14 25
* chi-square test testing differences between the three groups of physicians
† including 2 physicians who did not specify their specialty
‡ percentage of patients per physician, (e.g. 37% of the general practitioners indicated that 81-100% of their patients were using opioids at the moment of
death), percentages of physicians who had at least one death after a sickbed (non-sudden) in 2008
Rurup et al. BMC Palliative Care 2010, 9:23
http://www.biomedcentral.com/1472-684X/9/23
Page 4 of 12
significantly more often employed full-time than physi-
cians who completed the full questionnaire (80% vs.
55%), but had significantly less experience with prescrib-
ing opioids (85% vs. 99% in the past year) and with care
at the end of life (84% vs. 97% in the past year). Further-
more, the full questionnaire was significantly more often
completed by women than the non-response question-
naire. Finally, physicians who completed the non-
response questionnaire rated their own knowledge of
opioids and pain management on average somewhat
lower than physicians who completed the full question-
naire (6.8 vs. 7.2), but this difference was not statistically
significant.
The most important reasons for non-response were
“too busy”, “no time” and “too many studies”. Other rea-
sons for non-response were lack of experience with care
at the end of life in 18% and 12% thought they lacked
the knowledge to complete the questionnaire.
Knowledge statements
In Table 2 the answers to the knowledge statements are
shown per specialty. Of the 14 presented statements,
general practitioners and elderly care physicians gave on
average between 10 and 11 correct answers, clinical spe-
cialists gave on average between 9 and 10 correct
answers. With statements 3, 6, 7, 9 and 10 more than
20% of the physicians marked that the statement was
true when it was false, or the other way around. The
answers of clinical specialists were significantly less
often correct than the answers of general practitioners
and/or elderly care physicians on the statements 1,2,9
and 11-14.
Attitudes concerning pain, the prescription of opioids
and asking for advice
The majority of the physicians (60%) found good pain
control in practice complex (Table 3). If physicians
needed advice about pain management, they consulted
their direct colleagues (74%), their pharmacist (53%) or
the palliative care consultation team (not in Table).
Most physicians did know of the availability of the con-
sultation team (90%), but 40% had never used it. The
large majority (95%) indicated they were open to unsoli-
cited advice from the pharmacist.
The majority of the physicians (83%) indicated that
they combined opioids with a laxative. Clinical specia-
lists did not see constipation often as a side-effect.
Elderly care physicians indicated that it was not always
possible to prescribe opioids to their patients because it
was not necessary or because it would be too burdening.
The majority of the physicians (92%) indicated that
they did not combine opioids with an anti-emetic. Many
physicians said they waited to see whether the patient
developed nausea.
Attitudes and experiences concerning opioid rotation,
tolerance, addiction and shortening of life by opioids
Table 4 shows that in practice, clinical specialists less
often rotate opioids than general practitioners and
elderly care physicians (47% versus 70% and 66% often
or sometimes). A majority of all physicians (74%), espe-
cially among clinical specialists (85%) had sometimes or
frequently experienced that tolerance could occur with
the use of opioids, but less frequently thought tolerance
hampered the usage of opioids in pain control (20%).
Elderly care physicians experienced pressure from
people around the patient to increase the opioids in the
hope of hastening death significantly more often than
general practitioners and clinical specialists (75% vs.
respectively 36% and 50% sometimes or often). One in
10 physicians at least sometimes increased the dosage of
opioids above the level needed for pain and symptom
control with the explicit aim to hasten the death of the
patient. Clinical specialists and general practitioners did
this more often than elderly care physicians (respectively
19% and 11% vs. 1%, Table 4).
Side-effects
Most commonly observed side effect were constipation
(observed 86%), nausea (33%), drowsiness (30%), and
delirium (9%). Although less than 1% of the physicians
reported often observing life-threatening respiratory
depression, it was observed seldom by 61% of the clini-
cal specialists. General practitioners (60%) and elderly
care physicians (62%) said they never observed this pos-
sible side-effect.
Education and self-knowledge vs. knowledge
In Table 5 the relation is shown between education and
the estimates of own knowledge vs. the number of cor-
rect answers to the 14 knowledge statements. Physicians
who answered more knowledge statements correctly,
had more often received specific training in palliative
care.
Physicians who graded their own knowledge about
pain management and opioids higher, answered more
knowledge statements correctly. About a quarter of the
physicians who answered one to nine of the knowledge
statements correctly lowered their grade when asked
again at the end of the questionnaire.
The majority of the physicians (83%) would like to
receive additional education about one or more subjects
related to the end of life (not in Table). Almost half of
the physicians (46%) indicated they were interested in
opioid rotation, pain- and symptom management in
general (44%), palliative sedation (30%), pharmacological
mechanism of opioids (18%), side-effects (16%), and
other subjects (5%). Some physicians who said there
were not enough options for education said that
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Table 2 Answers to the knowledge statements per specialty*
General
practitioners
Elderly
care
physicians
Clinical
specialists
p-value† Total
n = 182 n = 110 n = 112 n = 406
Average number of correct answers 10,4 10,6 9,5 10,2
% % % %
Pain
1. In the management of pain it is important to differentiate
between nociceptive and neuropathic pain
% true
% false
% don’t know
98
1
1
100
0
0
94
0
6
<0.05 97
1
2
2. Administration of opioids early on in the disease hampers good
pain control later on in the disease process
% true
% false
% don’t know
3
96
2
8
91
1
10
84
6
<0.05 6
91
3
3. Opioids may cause or worsen pain % true
% false
% don’t know
26
45
29
34
43
23
35
43
22
≥0.05 30
45
25
Prescribing opioids
4. Once opioids have been started, other analgesics should be
discontinued
% true
% false
% don’t know
4
96
1
1
99
0
5
92
3
≥0.05 4
96
1
5. Opioids are only indicated for cancer patients % true
% false
% don’t know
0
100
0
0
100
0
2
98
0
≥0.05 0
100
0
6. Simultaneous prescription of a weak opioid (e.g. tramadol) and a
strong opioid (e.g. morphine) is contra-indicated‡
% true
% false
% don’t know
49
28
22
57
26
17
57
29
14
≥0.05 54
28
19
7. Decreased renal function raises plasma concentration of morphine
(-metabolites)
% true
% false
% don’t know
51
22
27
55
23
22
57
23
19
≥0.05 54
22
23
8. Opioids have a maximum dosage % true
% false
% don’t know
4
94
2
4
93
3
8
88
4
≥0.05 5
92
3
Side-effects
9. Life-threatening respiratory depression is a real danger when
titrating morphine against pain
% true
% false
% don’t know
16
83
2
19
75
6
31
68
1
<0.05 21
77
3
10. Drug management of nausea in treatment with opioids is
evidence-based
% true
% false
% don’t know
40
18
42
50
12
38
34
17
50
≥0.05 41
16
43
Opioid rotation*
11. You want to change a daily dosage of 60 mg oxycodon to a
fentanyl patch with an equivalent dosage. The strength of the patch
is.**
% 25 μg p/h†
% 50 μg p/h†
% false
% don’t know
28
38
6
28
37
34
12
17
25
24
11
41
<0.05 30
33
9
28
Sedation and shortening of life by opioids
12. Opioids titrated against pain, shorten life % true
% false
% don’t know
3
96
1
2
95
3
14
81
6
<0.05 6
91
3
13. Opioids are the favoured drugs for palliative sedation % true
% false
% don’t know
13
86
1
5
95
0
34
57
8
<0.05 17
81
3
14. Opioids are appropriate drugs to perform euthanasia % true
% false
% don’t know
0
99
1
0
97
3
8
86
6
<0.05 2
95
3
* correct answer is printed in bold.
†chi-square test testing differences between the three groups of physicians.
‡ a simultaneous prescription of a weak and a strong opioid is not a contra-indication in the true sense of the word. It is, however, for pharmacodynamic reasons
in general not a sensible combination. This is why it is not advocated in the available guidelines for treatment of pain.
** physicians could circle the following options 12/25/50/75/100/125/150 μg per hour or “don’t know”. With this question 2 answers were considered correct,
because different guidelines give different conversions, which leads to two different answers.
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offerings for education often came from the pharmaceu-
tical industry, that education did not include the sub-
jects they were interested in, that there was not a lot of
education in the form of courses or that courses were
not in their region. For the majority, the preferred way
of education was symposia or conferences (60%) and lit-
erature in Dutch journals (52%).
Linear regression analysis
A linear regression analysis was done, with as the depen-
dent variable the number of correct answers to the
knowledge statements. Background characteristics and
experience were included as independent variables: speci-
alty of the physician (general practitioner/elderly care
physician/clinical specialist), gender, year of graduation,
full-time or part-time employment, specific education in
palliative care, number of patients to whom opioids had
been prescribed in the past year, number of patients who
had died non-suddenly in the past year. The resulting
model (R2 = 0.16) showed that more experience with pre-
scribing opioids and having received a specific education
in palliative care have a positive influence on the number
of correctly answered knowledge statements. Further-
more the variable “clinical specialist"(vs. general practi-
tioner and elderly care physician) had an independent
negative influence on the number of correctly answered
statements. Finally, men answered less statements cor-
rectly than women did. (Table 6).
Discussion
Studying the knowledge level of physicians concerning
pain management presents a number of challenges,
because pain management is not a “hard science”. It
cannot be mastered by knowing a number of facts, but
this method of study only allows for testing such facts.
We have limited the knowledge statements almost
exclusively to knowledge about which consensus has
been reached and which is incorporated in pain man-
agement guidelines. Even then, it is difficult to make
true or false statements. Physicians’ whose answer is
considered ‘wrong’ may have good reasons to think their
answer is correct. We cannot set a limit of the number
of statements that should be answered correctly to be
an adequate physician.
We can conclude that several statements were
answered correctly by the majority of the physicians. In
our study physicians answered on average 10 out of 14
knowledge statements correctly (71%). In various studies
physicians scored between 31% and 68% correct answers
[29,30,54], although the overall scores in different stu-
dies cannot be compared as such because other state-
ments were used.
Table 3 Attitudes and experiences concerning pain, the prescription of opioids and consultation
General
practitioners
Elderly care
physicians
Clinical
specialists
p-value* Total
n = 182 n = 110 n = 112 n = 406†
% agree % agree % agree % agree
Pain
• In case of a change in pain symptomatology, I always take a comprehensive
pain history
74 64 73 ≥0.05 70
• In practice I find good pain control complex 60 56 65 ≥0.05 60
• With the current medical possibilities, pain is always controllable 21 26 29 ≥0.05 24
• When a patient is in pain, he/she will always indicate this 16 8 17 ≥0.05 14
Prescribing opioids
• When prescribing opioids, I always prescribe a maintenance dosage plus a
dosage to be used when needed (break-through medication)
90 68 84 ≥0.05 80
• Nursing/care staff are reluctant to administer the opioids I prescribe 4 4 10 ≥0.05 6
• I try to delay the prescription of opioids for as long as possible 4 9 7 ≥0.05 6
Consultation
• Inadequate support from the pharmacist, hampers pain management 7 8 3 ≥0.05 6
• Asking for consultation feels like personal defeat 2 2 4 ≥0.05 2
% yes % yes % yes % yes
Laxative and anti-emetic
• As a general rule, I combine the prescription of an opioid with a laxative 94 69 76 <0.05 83
• As a general rule, I combine the prescription of an opioid with an anti-
emetic
8 2 13 ≥0.05 8
* chi-square test testing differences between the three groups of physicians
† including 2 physicians who did not specify their specialty
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We also identified some points where there was lack
of knowledge in a considerable part of the physicians.
E.g. less than one in three physicians was aware that
opioids may cause or worsen pain. Although this is a
rare effect the clinical effects can be significant if the
dose of opioids is increased instead of decreased when a
patient suffers from opioid-induced pain sensitivity
[39-42]. There also seemed to be a lack of awareness
that decreased renal function raises plasma concentra-
tion of morphine(-metabolites). If a patient has
decreased renal function, certain opioids are preferred
above others, to prevent side-effects [55,56]. It is also
crucial that physicians involved in end of life care are
aware that opioids are not the drug of choice for pallia-
tive sedation. More than one in three clinical specialists
thought that opioids are the favoured drugs for palliative
sedation. According to Dutch guidelines for palliative
sedation, sedation with opioids should be considered
malpractice [53].
Hastening the end of life
Although the majority of the general practitioners and
the elderly care physicians said they had never experi-
enced life-threatening respiratory depression as a side-
effect of opioids, part of the general practitioners and
elderly care physicians (respectively 16% and 19%) did
think this was a real danger, even when titrated against
pain. Among clinical specialists even a third thought
this was a real danger, although many studies have
shown that this is not the case [22,23,49-53]. However,
this knowledge seems to conflict with practice as 48% of
all physicians take hastening of the patient’s death into
account when titrating opioids. And it appears that phy-
sicians act upon this misconception: 19% of the clinical
specialists and 11% of the general practitioners indicated
that they increased the dosage of opioids to a level
above what is needed for pain and symptom control
with the explicit aim to hasten the death of the patient.
A surprisingly large percentage of the elderly care
physicians (75%) did feel pressured sometimes or often
by relatives of a patient or other persons to increase the
dosage of opioids in the hope of hastening death. Possi-
bly this is related to the fact that elderly care physicians
often care for patients with dementia who are unable to
discuss medical decisions with their physician.
This result illustrates that good care at the end of
life is more comprehensive than prescribing the right
(dosage of) drugs. Contact and communication with
Table 4 Attitudes and experiences concerning opioid rotation*, tolerance**, addiction and shortening of life by
opioids
General
practitioners
Elderly care
physicians
Clinical
specialists
p-value† Total
n = 182 n = 110 n = 112 n = 406†
%often/
sometimes
%often/
sometimes
%often/
sometimes
%often/
sometimes
Opioid rotation*
• I rotate opioids in practice 70 66 47 <0.05 62
• I rotate opioids if pain control is inadequate 77 72 65 ≥0.05 72
• I rotate opioids in case of side-effects 67 73 63 ≥0.05 67
• I find calculating of opioid dosages when rotating difficult 62 57 57 ≥0.05 59
Tolerance** and fear of addiction
• I have noticed that tolerance can develop in the usage of opioids 68 74 85 <0.05 74
• Tolerance hampers the usage of opioids in pain control 15 20 29 <0.05 20
• Patients’ fear of addiction hampers the usage of opioids in practice 49 35 51 <0.05 46
Shortening of life by opioids
• It occurs that relatives of a patient or other persons concerned, put
pressure on me to increase the opioids in the hope of hastening death
36 75 50 <0.05 50
• When titrating the dosage of opioids upwards against pain, I take into
account that this may hasten the death of the patient
38 44 68 <0.05 48
• It occurs that I increase the dosage of opioids to a level above that of
what is needed for pain and symptom control with the explicit aim to
hasten the death of the patient
11 1 19 <0.05 10
* The following definition of tolerance was given in the questionnaire: “By tolerance for a drug we mean that a patient needs a higher dose to reach the same
pain relief while the pain stimulus remains the same. Tolerance has proven to be difficult to measure in practice, we are interested in your personal experience.”
† chi-square test testing differences between the three groups of physicians.
‡ including 2 physicians who did not specify their specialty.
** The following definition of opioid rotation was given in the questionnaire: “With the term “opioid rotation” we mean the replacing of one opioid by another
opioid.”
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relatives are crucial in palliative care. It also shows that
the misconception that high dosages of opioids hasten
the end of life probably also exists among relatives and
patients. In practice, only an overdose of opioids could
hasten the end of life. Even then hastening death is
not likely, but there is an increased risk of serious
side-effects, such as a delirium [22,23,49-53]. For that
reason the Dutch guideline about euthanasia drugs
states that not opioids but barbiturates followed by
neuromuscular relaxants are to be used for euthanasia
[57]. Nevertheless, this study shows that 8% of the
clinical specialists does think opioids are appropriate
drugs for euthanasia.
However, it seems that the proportion of physicians
acting upon this misconception is decreasing the last
years. The proportion of opioids as drugs in euthanasia
deaths has decreased from 21.6% in 2001 to 16.2% in
2005[11], making it likely that the knowledge of opioids
in end of life has increased.
Opioid rotation
Rotation of opioids means that one opioid is substituted
by another. This can be done in case of inadequate pain
management or in case of side-effects. A quarter of the
clinical specialists said they never rotated opioids. Many
physicians said they had difficulties calculating opioid
Table 5 Relation between education and the estimates of own knowledge vs. the number of correct answers to the 14
knowledge statements
3-9 correct
answers
10 correct
answers
11 correct
answers
12-14 correct
answers
p-value*
N = 114 N = 95 N = 105 N = 93
% % % %
Received specific education in palliative care 60 68 78 87 <0.05
Grade given for own knowledge before completing the
questionnaire (1-10)†
<0.05
• <5.5 11 1 1 3
• 5.5-6.5 19 11 10 5
• 6.6-7.5 46 60 51 46
• 7.6-8.5 20 27 34 41
• 8.6-10 5 1 5 4
Grade given for own knowledge after completing the
questionnaire (1-10)†
≥0.05 <0.05
• <5.5 11 1 3 2
• 5.5-6.5 24 6 8 6
• 6.6-7.5 48 61 50 41
• 7.6-8.5 15 32 37 46
• 8.6-10 2 0 4 6
Are there enough options for you for additional education about
opioids and pain management?
<0.05
• Yes 77 94 93 95
• No 23 6 7 5
* chi square test to test differences in physician characteristics for physicians with different numbers of correct answers (categorized in 4 groups).
† Physicians graded their own knowledge about opioids and pain management by scoring 1-10. After completing the knowledge statements, respondents were
asked to again grade their own knowledge. Physicians could not see how they did on the knowledge statements, they did not receive the answers to the
knowledge statements immediately after completing the questionnaire.
Table 6 Physician characteristics related to the number of correct answers on the knowledge statements (multivariate
linear regression; n = 406)
Dependent variable Independent variables* Beta (standardised regression
coefficient)
p
• Number of correct answers on the
knowledge statements
• Number of patients to whom the respondent
prescribes opioids per year
.22 <0.001
• Received specific education in palliative care .18 <0.001
• Clinical Specialist -.16 <0.001
• Man -.10 0.03
* variables that were analysed, but were not significant in the final model: year of graduation, full-time or part-time employment, number of patients that had
died non-suddenly in the past year
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dosages when rotating (59%) and many physicians were
interested in education about opioid rotation (46%). The
evidence for equianalgesic conversion rates is limited,
and equianalgesic doses vary among individuals under
varying conditions [58]. Clinical characteristics such as
organ dysfunction and age influence pharmacokinetics
and pharmacodynamics. Scientific insights are develop-
ing and sometimes conflicting - for example concerning
the influence of age on pharmacokinetics of transdermal
fentanyl [59,60]. This might explain why standards men-
tion different equianalgesic conversions for opioids. Two
current Dutch guidelines present different conversion
factors for some types of opioids. The cause of this dif-
ference is unclear; possibly there is no evidence to for-
mulate unambiguous conversion factors. As a result of
this, the knowledge statement about opioid rotation in
this study has two possible answers. In our analyses,
both answers were considered correct. In practice the
reason for rotation is also relevant for the conversion
factor: in case of rotation because of side-effects, it is
recommended to convert to a lower than equivalent
dose, in case of rotation because of inadequate pain
relief it is recommended to rotate to an equivalent dose.
Asking for advice and education
Physicians had on average reasonable knowledge about
their own knowledge level. However, part of the physi-
cians who did not answer many knowledge statements
correct, did think their knowledge was adequate. It is
important that physicians know their limits, so they
know when to ask for assistance.
A remarkable high number of physicians (83%) was
interested in additional education about opioids or pain
management. It seems there are enough options for addi-
tional education in the Netherlands, but that this does
not always fit the wishes of the physicians. Physicians
were interested in efficient, objective education, prefer-
ably by parties other than the pharmaceutical industry.
Strengths and limitations of this study
A strength of this study is that it is the first study in the
Netherlands which has mapped the knowledge level of
physicians about the use of opioids and pain manage-
ment at the end of life. It has highlighted some impor-
tant gaps in the knowledge of Dutch physicians. The
results can be useful to improve (additional) education,
which is necessary to improve the quality of care at the
end of life. The statements used in this study can also
be used for training purposes, and in studies in other
countries with the same objectives as this study.
A limitation of this study is that only a limited number
of themes are highlighted in which physicians should
have adequate knowledge, and within those themes, not
all aspects can be studied. Other limitations are that the
response rate is moderate, and that the questionnaire has
not been validated, although the pilot study did not
reveal questions or answer categories that were not
understood by the respondents. Hence, the answer cate-
gory ‘don’t know’ should be interpreted as physicians that
did not know the answer to the question. Physicians who
participated in this study, assessed their own knowledge
somewhat higher than physicians who answered the non-
response questionnaire, so probably this study tends to
give a too positive image of the knowledge of physicians
rather than a too negative image. It is possible that the
knowledge about opioids and attitudes differ also within
the three groups of physicians, as a result of different
clinical specialty or experience in palliative care. We did
not analyse possible differences, as we did not design our
study to investigate these.
Conclusions
Although the effects of a gap in the knowledge about
opioids on the clinical practice differ per subject, we can
conclude that most of the knowledge questioned in our
study should be part of the basal knowledge physicians
should have, and that a gap in this knowledge can be a
barrier for adequate care at the end of life. Good care at
the end of life is more comprehensive than adequate
knowledge about pain management, but this is an essen-
tial part of it.
From this study -including physicians’ attitudes and
opinions as well as a test of their knowledge- three
areas emerge, in which it seems likely that an improve-
ment in these areas can improve the quality of pain
management at the end of life for many patients in the
Netherlands, namely: 1) palliative sedation, opioids are
too often erroneously considered the appropriate drug
for palliative sedation; 2) hastening the end of life with
opioids, opioids are too often erroneously thought to
shorten life, even when titrated against pain; 3) opioid
rotation, opioid rotation is considered a difficult area by
the majority of physicians, in which they would like
additional education.
Additional material
Additional file 1: Appendix 1 questionnaire. An English translation of
the study questionnaire
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